GeminIQ Website Logo

Viewing CAPR free

Subscribe for full history, 90+ metrics, screener, watchlist...

CAPRICOR THERAPEUTICS, INC.

CAPR

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
211052882023291168116159
Marketable Securities Current
---791001161401719342520
Available For Sale Securities Debt Securities Curr…
21717330---140-----
Grants Receivable Current
-0000010000101
Prepaid Expense And Other Assets Current
445211201110
Assets Current
2422833231011241461638631415130
Property Plant And Equipment Net
3629181186656665
Other Assets
Operating Lease Right Of Use Asset
8913141411112222
Other Assets
221010000000
Assets
3693263561261341541709338495937
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current
------876667
Accounts Payable Current
3423553-----
Accrued Liabilities Current
16111610745-----
Operating Lease Liability Current
110011111111
Other Liabilities Current
----------00
Government Assistance Liability Current
06633-0-----
Contract With Customer Liability Current
121212121212121315192425
Liabilities Current
333436282822212022263133
Other Long Term Debt Noncurrent
-------33333
Liabilities Noncurrent
Government Assistance Liability Noncurrent
--00033---3-
Operating Lease Liability Noncurrent
9014141400111112
Liabilities Noncurrent
9014141404444556
Liabilities
1234850432926252527313639
Contract With Customer Liability Noncurrent
----------01
Stockholders Equity
Common Stock Value
000000000000
Additional Paid In Capital Common Stock
626618610358354350344261191187182157
Accumulated Other Comprehensive Income Loss Net Of…
-0-00112100000
Retained Earnings Accumulated Deficit
-380-339-305-275-250-224-200-193-180-169-159-159
Stockholders Equity
2462793068410512814568121823-2
Liabilities And Stockholders Equity
3693263561261341541709338495937
Preferred Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Preferred Stock Shares Authorized
555555555555
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Authorized
100100100100100100100100100505050
Common Stock Shares Issued
585857464646464032323126
Shares Outstanding
585857464646464032323126

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-11.94%-23.48%-87.31%---------
202585.53%33.64%3.00%-13.81%-5.88%-16.75%383.63%409.17%293.71%0.03%-2.60%-14.36%
20240.77%-7.50%-25.19%17.78%156.44%461.34%-19.63%-15.58%-18.66%-14.64%-28.38%-10.62%
2023------22.59%80.40%31.89%15.86%-5.69%-2.07%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
7.35
8.42
9.01
3.59
4.37
6.55
7.77
4.19
1.37
1.57
1.63
0.90
Quick Ratio
7.22
8.28
8.88
3.50
4.33
6.48
7.70
4.17
1.33
1.53
1.59
0.88
Working Capital
209.17M
249.45M
287.10M
72.80M
95.73M
123.91M
142.36M
65.35M
8.31M
15.03M
19.59M
-3.40M
Leverage & Debt
Debt to Equity
0.50
0.17
0.16
0.51
0.27
0.20
0.17
0.36
2.33
1.68
1.60
-21.78
Debt Ratio
0.33
0.15
0.14
0.34
0.21
0.17
0.15
0.27
0.70
0.63
0.62
1.05
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.10
0.16
0.17
0.19
0.36
0.64
0.52
0.46
0.31
Per Share Metrics
Diluted EPS TTM
-2.23
-2.00
-2.26
-1.79
-1.53
-1.21
-1.15
-1.03
-0.88
-0.78
-0.83
-1.13
Free Cash Flow Per Share TTM
-1.98
-1.74
-1.56
-1.37
-1.20
-1.02
-1.17
-1.15
-1.11
-1.04
-1.00
-0.87
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Operating Profit Margin TTM
-
-
-
-778.77%
-548.13%
-329.89%
-191.12%
-155.62%
-110.50%
-96.53%
-95.63%
-219.67%
Net Profit Margin TTM
-
-
-
-736.62%
-522.51%
-317.13%
-181.71%
-146.86%
-102.93%
-89.72%
-88.52%
-208.16%
Growth Metrics
Net Revenue Growth (1Y)
-100.00%
-100.00%
-100.00%
-52.08%
-50.68%
-35.92%
-11.55%
65.33%
187.15%
389.30%
886.81%
943.31%
Net Income Growth (1Y)
84.94%
108.11%
159.58%
140.35%
150.39%
126.48%
81.57%
16.64%
-4.38%
-16.07%
-23.20%
6.39%
EPS Growth (1Y)
45.94%
65.36%
96.69%
73.97%
74.43%
55.60%
38.06%
-9.00%
-23.92%
-32.42%
-29.58%
0.68%
Valuation Metrics
P/E TTM
-10.78
-15.24
-12.77
-4.02
-6.49
-7.87
-12.01
-14.75
-5.43
-8.76
-5.88
-3.02
P/B TTM
5.67
6.26
4.39
3.93
4.32
3.39
3.34
7.37
13.20
11.55
5.79
-49.39
P/S TTM
-
-
-
29.61
33.89
24.94
21.82
21.67
5.59
7.86
5.20
6.28
Market Cap
1.39B
1.75B
1.34B
329.61M
453.89M
433.09M
486.02M
503.30M
151.89M
212.90M
130.95M
88.30M
Enterprise Value
1.37B
1.64B
1.13B
310.10M
430.65M
404.30M
474.73M
434.92M
141.20M
206.68M
116.25M
79.31M
Calculated Values
Free Cash Flow TTM
-114.90M
-99.76M
-72.72M
-62.77M
-54.68M
-46.62M
-41.16M
-38.03M
-35.44M
-32.65M
-26.91M
-22.35M
Net Debt
-20.94M
-105.42M
-216.30M
-19.51M
-23.24M
-28.79M
-11.29M
-68.38M
-10.69M
-6.21M
-14.69M
-8.98M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-25Sale
Owner: Krasney, Karen
Title: EVP, GENERAL COUNSEL
Shares: 24,100
Price/Share: $30.38
Value: $732,158.00
Shares Owned: 30,547
Relationship: Officer
Ownership: Direct
2026-06-25Sale
Owner: Bergmann, Anthony
Title: CHIEF FINANCIAL OFFICER
Shares: 24,100
Price/Share: $30.38
Value: $732,158.00
Shares Owned: 11,223
Relationship: Officer
Ownership: Direct
2026-06-24Sale
Owner: Bergmann, Anthony
Title: CHIEF FINANCIAL OFFICER
Shares: 400
Price/Share: $30.00
Value: $12,000.00
Shares Owned: 11,223
Relationship: Officer
Ownership: Direct
2026-06-24Sale
Owner: Krasney, Karen
Title: EVP, GENERAL COUNSEL
Shares: 400
Price/Share: $30.00
Value: $12,000.00
Shares Owned: 30,547
Relationship: Officer
Ownership: Direct
2026-05-01Sale
Owner: Bergmann, Anthony
Title: CHIEF FINANCIAL OFFICER
Shares: 25,000
Price/Share: $31.70
Value: $792,500.00
Shares Owned: 8,223
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
58.20%
Inst. Shares: 33,428,338
Shares Outstanding: 57,434,267
2025-12-31
58.88%
Inst. Shares: 27,368,429
Shares Outstanding: 46,478,416
2025-09-30
31.06%
Inst. Shares: 14,200,867
Shares Outstanding: 45,716,151
2025-06-30
29.59%
Inst. Shares: 13,525,508
Shares Outstanding: 45,709,071
2025-03-31
39.73%
Inst. Shares: 18,133,223
Shares Outstanding: 45,636,633

CAPRICOR THERAPEUTICS, INC. (CAPR) — SEC Financial Statements & Analysis

CAPRICOR THERAPEUTICS, INC. (CAPR) is a pharmaceutical preparations company, incorporated in DE. CAPRICOR THERAPEUTICS, INC. trades on Nasdaq as: CAPR. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), CAPRICOR THERAPEUTICS, INC. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.50x, a Price-to-Sales (P/S) ratio of 29.61x (TTM), a Price-to-Book (P/B) ratio of 5.67x (TTM), at a market cap of $1.39B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-100.00%
Debt To Equity
0.50x
P/S TTM
29.61x
P/B TTM
5.67x
Market Cap
$1.39B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is CAPRICOR THERAPEUTICS, INC. in?

CAPRICOR THERAPEUTICS, INC. (CAPR) operates in the Pharmaceutical Preparations industry.

What is CAPR's market cap?

CAPRICOR THERAPEUTICS, INC. (CAPR) has a market capitalization of $1.39B as of 2026-06-30.

What exchange does CAPR trade on?

CAPRICOR THERAPEUTICS, INC. (CAPR) trades on the Nasdaq.

Where is CAPRICOR THERAPEUTICS, INC. incorporated?

CAPRICOR THERAPEUTICS, INC. is incorporated in DE.

Wall Street's data.
Main Street's price.